SS

Shubham Suryakant Honrao

Active Director Designated Partner DIN 10015672
DIN 10015672 First appointment Aug 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Suryakant Honrao

Data last updated:

Shubham Suryakant Honrao is a Designated Partner at Infinity Pharma Lifesciences Llp (since 2022). The company operates in Business Services.

DIN 10015672
Primary Designation Designated Partner
Industry Business Services
First Appointment 16 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Aug 20222022Active

Board colleagues of Shubham Suryakant Honrao

NameDINCompanyDesignation
Shubhangi Suryakant Honrao10015673Infinity Pharma Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Infinity Pharma Lifesciences Llp
Premium access

Shareholding and investment profile for Shubham Suryakant Honrao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Suryakant Honrao

Shubham Suryakant Honrao currently holds 1 directorship: Infinity Pharma Lifesciences Llp (Designated Partner, since 16 Aug 2022).

Shubham Suryakant Honrao was first appointed on 16 Aug 2022 as Designated Partner at Infinity Pharma Lifesciences Llp.

The current boards of Shubham Suryakant Honrao's companies include Shubhangi Suryakant Honrao (Infinity Pharma Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available